Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti‐melanoma differentiation‐associated gene 5 dermatomyositis-Reference-Cited by-同舟云学术

Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti‐melanoma differentiation‐associated gene 5 dermatomyositis

Published:2018-09-26 Issue:5 Volume:180 Page:1090-1098
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Zhang S.H.¹^ORCID,Zhao Y.¹,Xie Q.B.¹,Jiang Y.²,Wu Y.K.³,Yan B.¹^ORCID

Affiliation:

1. Department of Rheumatology West China Hospital Sichuan University No. 37 Guoxue Lane Chengdu 610041China

2. Department of Pathology West China Hospital Sichuan University No. 37 Guoxue Lane Chengdu 610041China

3. Department of Laboratory Medicine West China Hospital Sichuan University No. 37 Guoxue Lane Chengdu 610041 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.16917

Reference39 articles.

1. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance

2. New tools for diagnosis and therapy

3. MDA5 autoantibody—another indicator of clinical diversity in dermatomyositis

4. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis

5. Anti-Melanoma Differentiation-Associated Protein 5-Associated Dermatomyositis: Expanding the Clinical Spectrum

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐PL‐12 anti‐synthetase syndrome manifesting with multiple digital ischemia: Case report & review of the literature;Clinical Case Reports;2024-08-28

2. Case Report: Contiguous presentation of anti-MDA5 juvenile dermatomyositis and anti-AQP4 neuromyelitis optica spectrum disorder in an adolescent patient;Frontiers in Pediatrics;2024-06-14

3. Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis;Modern Rheumatology Case Reports;2024-04-10

4. Novel B-cell subsets as potential biomarkers in idiopathic inflammatory myopathies: insights into disease pathogenesis and disease activity;Journal of Leukocyte Biology;2024-03-30

5. Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease;Rheumatology International;2024-03-08